slide 1

FGID DEPARTMENT

Director :

Mostafa Reisi. MD

Research Field of Interest :

  • Clinical trials (new strategies and treatment for disease)
  • Epidemiologic studies to evaluate functional gastrointestinal disease. (eg. impact on quality of life)
  • Clinical research: (diagnosis and association of disease)

Members

slide 1
Articles

Effects of Ramadan Fasting on Dyspepsia Symptoms---136

Background: A few studies have shown that during Ramadan, gastrin, pepsin, and acid secretion are increased and some changes in nutrition of fasting people may deteriorate dyspepsia symptoms. On the other hand stopping smoking and alcohol use and probable psychosocial factors may improve dyspepsia symptoms.

View More

Effectiveness of Quercus brantii hydro alcoholic extract on dyspepsia: A randomized, double blind clinical trial---137

Background: We aimed to evaluate the effectiveness of hydroalcoholic extract of Quercus brantii’s nut on clinical, endoscopic, and pathological fi ndings of patients with dyspepsia.

View More

Health related quality of life in irritable bowel syndrome patients, Kashan, Iran: A case control study---139

Background: Irritable bowel syndrome has significant impacts on the quality of life (QOL) but IBS subtypes may be different in QOL. This study aimed to assess QOL in IBS subtypes and also two prevalent questionnaires applied to evaluate the QOL in IBS.

View More

Synbiotic containing Bacillus coagulans and fructo-oligosaccharides for functional abdominal pain in children---140

Background: We evaluated the effectiveness of a synbiotic in the treatment of childhood functional abdominal pain (FAP). Probiotics are effective in the treatment of functional gastrointestinal disorders in adult patients, but there is lack of information in children.

View More

Citalopram for pediatric functional abdominal pain: a randomized, placebo-controlled trial---141

Background: Antidepressants are effective in adults with pain-related functional gastrointestinal disorders. We investigated the effectiveness of citalopram in the treatment of childhood functional abdominal pain (FAP).

View More

Mebeverine for Pediatric Functional Abdominal Pain: A Randomized, Placebo-Controlled Trial---142

Background: Few studies are conducted on the efficacy of antispasmodics in the treatment of functional gastrointestinal disorders in children. We evaluated the effectiveness of a smooth-muscle relaxant (mebeverine) in the treatment of childhood functional abdominal pain (FAP).

View More

Premedication with sublingual or oral alprazolam in adults undergoing diagnostic upper gastrointestinal endoscopy---166

Background: Diagnostic esophagogastroduodenoscopy (EGD) is uncomfortable for most patients. We determined the efficacy of alprazolam, administered orally or sublingually, as premedication for sedation during EGD.

View More

Comparison of Lactobacillus Sporogenes plus mineral oil and mineral oil alone in the treatment of childhood functional constipation---143

Background: Functional constipation is one of the most prevalent childhood gastrointestinal disorders. We evaluated effects of adding a probiotic to mineral oil in the treatment of functional constipation in children.

View More

Irritable Bowel Syndrome–like Symptoms in Patients with Inflammatory Bowel Disease in Clinical Remission Phase are Related to Gut Inflammation---144

Background: Symptoms consistent with irritable bowel syndrome (IBS) are common among IBD patients in remission phase, and clinicians have difficulties in interpreting such symptoms as an ongoing disease activity or a coexistent IBS. We investigated if the assessment of Fecal Calprotectin (FC) could be helpful in this regard

View More

Linguistic Validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian Patients---145

Background: There is a growing interest of clinical and epidemiological researches in the field of functional gastrointestinal disorders in our society. Accordingly, validated and culturally adapted instruments are required for appropriate measurement of variables specially the quality of life. The aim of our study was the linguistic validation of the Irritable Bowel Syndrome-Quality of Life questionnaire (IBS-QOL) for Iranian IBS patients with Persian language

View More

Comparing the efficacy of biofeedback and balloon-assisted training in the treatment of dyssynergic defecation---146

Background: Dyssynergic defecation does not respond appropriately to routine treatments for constipation. Recently, research has shown that biofeedback therapy is useful in anorectal dyssynergia. To compare two treatment modalities for patients experiencing dyssynergic defecation.

View More

The Effectiveness of Coping Strategies Training on Symptom Severity, Quality of Life and Psychological Symptoms among Patients with Irritable Bowel Syndrome---147

Background: Various psychological interventions were considered as part of the treatments of irritable bowel syndrome. However, the effectiveness of coping strategies in improving symptoms of this disease remains unclear. The objective of this study was to assess the effects of coping strategies training in treatment of irritable bowel syndrome (IBS).

View More

Which End Point Is More Comprehensive in Refl ecting Changes in Irritable Bowel Syndrome Treatment Trials? ---148

Is microscopic colitis a missed diagnosis in diarrhea-predominant Irritable Bowel Syndrome? ---167

Background: There are controversies about the importance of biopsies of normal colon mucosa in the investigation of patients with diarrhea predominant irritable bowel syndrome (IBS). On the other hand, microscopic colitis may be missed based on normal colonoscopy and laboratory examination in this group of patients

View More

Colonoscopic diagnosis of appendiceal intussusception in a patient with intermittent abdominal pain: A case report---149

Background: Intussusception of the appendix is a rare condition. Most cases are diagnosed during operation of the patients suspected to have appendicitis. In this report we present a seventy one year-old man with a history of periumbilical intermittent abdominal pain for several months.

View More

Where Does Hypnotherapy Stand in the Management of Irritable Bowel Syndrome? A Systematic Review---150

Background: Irritable bowel syndrome (IBS) is a gastrointestinal disorder characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause. Despite its prevalence, there remains a significant lack of efficient medical treatment for IBS to date. However, according to some previous research studies, hypnosis has been shown to be effective in the treatment of IBS. To determine the definite efficacy of hypnosis in the treatment of irritable bowel syndrome.

View More

Airway resistance in irritable bowel syndrome as measured by impulse oscillometry ---151

Background: Irritable bowel syndrome (IBS) is associated with bronchial asthma. However, published data on airway resistance or impedance in patients with IBS but without any respiratory symptoms are lacking.
 

View More

Effects of Ramadan fasting on acute upper gastrointestinal bleeding due to peptic ulcer ---152

Background: As, acid negatively affects duodenal and gastric mucosal defense, we designed this study to investigate if fasting during Ramadan can promote peptic ulcer and its complication, acute upper gastrointestinal bleeding.

View More

Research Projects

Combination of diclofenac and aggressive hydration for the prevention of post-ERCP pancreatitis

PI: Mehri Hajalikhani, MD
Colleagues: Mahsa Khodadoustan, Mohammad Hassan Emami, MD
Funded by: Poursina Hakim Digestive Disease Research Center, Isfahan University of Medical Sciences

 
http://journals.sbmu.ac.ir/ghfbb/index.php/ghfbb/article/view/1424



Relationship between stress-coping strategies with severity of gastrointestinal symptoms, psychological factors and quality of life in patients with irritable bowel syndrome

PI: Mehrdad Zeynalian, MD
Colleagues: Seyed Mohammad Hassan Emami, MD

 



Sleep hygiene knowledge and practice in association with sleep quality in patients with irritable bowel syndrome

PI: Leyla Mirbagher
Colleagues: Seyed Mohammad Hassan Emami, MD

 



Evaluting the effect of Simethicone on decreasing foam and bubbles during upper gastrointestinal endoscopy

PI: Farnaz Torkzade
Colleagues: Seyed Mohammad Hassan Emami, MD
 



Evaluation of effectiveness of Fluoxetine on symptom and Quality of Life in Patients with Irritable Bowel Syndrome

PI: Forough Ghasedi. Ali Gholamrezai
Colleagues: Seyed Mohammad Hassan Emami, MD. Khoram, MD. Adilipour,MD. Tavakoli,MD

 



Evaluation of effectiveness of citalopram on symptoms and quality of life of patients with irritable bowel syndrome

PI: Hamid Tavakoli, MD
Colleagues: Seyed Mohammad Hassan Emami, MD. Khoram, MD. Adilipour,MD. Gholamrezai, MD

 



Evaluation of the Prevalence of Gastrointestinal Disorders in Isfahan

PI: Falah, MD. Abutalaian, MD
Colleagues: Seyed Mohammad Hassan Emami, MD. Khoram, MD. Adilipour,MD. Tavakoli,MD. Kabiri, MD. Talaei, MD.Farajzadegan, MD. Adibi, MD. Gholamrezai, MD

 



Evaluation of effectiveness of Yoga on Symptom and Quality of Life in Patients with Irritable Bowel Syndrome

PI: Atati, MD
Colleagues: Seyed Mohammad Hassan Emami, MD. Khoram, MD. Adilipour,MD. Tavakoli,MD. Gholamrezai, MD

 



Evaluation of effectiveness of hypnotherapy on the symptoms and quality of life of patients with irritable bowel syndrome

PI: Gholamrezai, MD
Colleagues: Seyed Mohammad Hassan Emami, MD. Khoram, MD. Adilipour,MD. Tavakoli,MD

 



Evaluation of effectiveness of recovery expectation and belief in cure in response to psychological treatment of irritable bowel syndrome

PI: Gholamrezai, MD
Colleagues: Seyed Mohammad Hassan Emami, MD. Nemati, MD. Daghaghzade, MD

 



Predicting the prognosis of Balloon Dilation therapy in Achalasia patients, Using a Novel Visual Scale

PI: Mehran Haghighi
Colleagues: Seyed Mohammad Hassan Emami, MD

 



Determination of Pulmonary Airway Resistance in Patients with Irritable Bowel Syndrome (Al-Zahra Hospital, Bamdad clinic 2004-2005)

PI: Behzad Dourshi
Colleagues: Babak Amra, MD

 



Study of the validation of irritable bowel syndrome quality of life questionnaire (IBS-QOL) for Iranian patients

PI: Ali Afshari
Colleagues: Seyed Mohammad Hassan Emami, MD

 



Determination of prevalence of causes of GIB and its treatment in patients hospitalized in Al- Zahra hospital of Isfahan in 1998

PI: Ali Afshari
Colleagues: Seyed Mohammad Hassan Emami, MD

 



Reflux and its effect on the severity of respiratory diseases- 2005- Chemical War Veterans of Isfahan 2006

PI: Bijan Ebrahimi, MD
Colleagues: Seyed Mohammad Hassan Emami, MD



The effect of fasting on dyspepsia symptom in 2015 and 2016 in Isfahan

PI: Hojatollah Rahimi, MD
Colleagues: Seyed Mohammad Hassan Emami, MD
Funded by: Poursina Hakim Digestive Disease Research Center

 



Evaluation of effectiveness of Fluvoxamine on Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome

PI: Agah, MD
Colleagues: Seyed Mohammad Hassan Emami, MD. Gholamrezai,MD



The structural pattern of the relationship between the Severity of symptoms, Illness perception and Resilience with Health-related quality of life in IBS patient

PI: Ghazale Teymouri
Colleagues: Elnaz Sajadyan, MD
Funded by: Islamic Azad University Isfahan (Khorasgan) Branch Research Center

 



Comparison of the effects of Aripiprazole with Nortriptyline on Irritable bowel syndrome

PI: Hojatolah Rahimi, MD
Colleagues: Seyed Mohammad Hassan Emami, MD
Funded by: Poursina Hakim Digestive Disease Research Center

 



The effect of fasting on symptoms of reflux disease in 2015 and 2016 in Isfahan

PI: Hojatolah Rahimi, MD
Colleagues: Seyed Mohammad Hassan Emami, MD
Funded by: Poursina Hakim Digestive Disease Research Center

 



All rights reserved by Poursina Halkim poursinahakim.com